BioCentury
ARTICLE | Company News

Galderma sales and marketing update

October 7, 2013 7:00 AM UTC

Galderma launched Mirvaso brimonidine tartrate 0.33% in pharmacies in the U.S. to treat facial erythema of rosacea in adult patients. A 30 g tube of the product, which was approved by FDA in August, ...